Stay informed with the latest updates for the inheritable blood disorders community.

Industry
OPKO Health Submits Application to FDA for Long-Acting Factor VIIa
OPKO Health Submits Application to FDA for Long-Acting Factor VIIa
Medical
Inhibitor Chapter Updated in Nurses’ Guide to Bleeding Disorders
Inhibitors in Hemophilia Chapter Now Available in NHF’s…
Medical
Plant-Based Inhibitor Therapy Continues to Evolve
Plant-Based Inhibitor Therapy Continues to Evolve
Medical
Inhibitor Chapter Updated in Nurses’ Guide to Bleeding Disorders
PDF Now Available for Nurses’ Guide Chapter on von Willebrand Disease
NBDF & Community
New NHF Brochure on Prolonged Half-Life Factor Products
New NHF Brochure on Prolonged Half-Life Factor Products
Blood Safety
Donor Deferral Policy Change and National Blood Monitoring System Established
Donor Deferral Policy Change and National Blood Monitoring System…
Blood Safety
CDC Updates Consumers on Ebola and Blood Safety
CDC Updates Consumers on Ebola and Blood Safety
Medical Advisory
Medical Advisory
…
NBDF & Community
NHF Announces 2020 Excellence Fellowship Awards
Research Excellence Fellowships 2014
Medical
St. Jude/WFH to Bring Hemophilia B Gene Therapy Trials to Developing World
Gene Therapy Study Still Succeeding 3 Years Later
Advocacy & Legislative
Marketplace Open Enrollment Begins Nov. 15
Marketplace Open Enrollment Begins Nov. 15
Medical
Certification Program Now Available for Hematology Nurses
PDF Now Available for Nurses’ Guide Chapter on Women with Bleeding…
Medical
NHF’s MASAC Issues Three New Documents
NHF’s MASAC Issues Three New Documents
Medical
FDA Accepts License Application and Grants Priority Review for Emicizumab
FDA Approves Oral HCV Combination
Medical
Register Now for ASH Precon Symposium
Register Now for ASH Precon Symposium